相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Evidence that Non-Fibrillar Tau Causes Pathology Linked to Neurodegeneration and Behavioral Impairments
Kurt R. Brunden et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Passive Immunization with Anti-Tau Antibodies in Two Transgenic Models REDUCTION OF TAU PATHOLOGY AND DELAY OF DISEASE PROGRESSION
Xiyun Chai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Immunotherapy for Alzheimer's disease
D. Morgan
JOURNAL OF INTERNAL MEDICINE (2011)
Passive immunization targeting pathological phospho-tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain
Allal Boutajangout et al.
JOURNAL OF NEUROCHEMISTRY (2011)
被撤回的出版物: Intraneuronal APP, Not Free Aβ Peptides in 3xTg-AD Mice: Implications for Tau versus Aβ-Mediated Alzheimer Neurodegeneration (Retracted article. See vol. 35, pg. 3724, 2015)
Matthew J. Winton et al.
JOURNAL OF NEUROSCIENCE (2011)
Naturally Occurring Autoantibodies against β-Amyloid: Investigating Their Role in Transgenic Animal and In Vitro Models of Alzheimer's Disease
Richard Dodel et al.
JOURNAL OF NEUROSCIENCE (2011)
Amyloid-β and tau - a toxic pas de deux in Alzheimer's disease
Lars M. Ittner et al.
NATURE REVIEWS NEUROSCIENCE (2011)
Tau-Targeted Immunization Impedes Progression of Neurofibrillary Histopathology in Aged P301L Tau Transgenic Mice
Mian Bi et al.
PLOS ONE (2011)
Hsp90 regulates tau pathology through co-chaperone complexes in Alzheimer's disease
Antero Salminen et al.
PROGRESS IN NEUROBIOLOGY (2011)
TDP-43 and FUS: a nuclear affair
Dorothee Dormann et al.
TRENDS IN NEUROSCIENCES (2011)
FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration
Hazel Urwin et al.
ACTA NEUROPATHOLOGICA (2010)
Sertraline for the Treatment of Depression in Alzheimer Disease: Week-24 Outcomes
Daniel Weintraub et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2010)
Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models
Lars M. Ittner et al.
CELL (2010)
Efficacy and safety of immunization with phosphorylated tau against neurofibrillary tangles in mice
Moran Boimel et al.
EXPERIMENTAL NEUROLOGY (2010)
Interneuronal Transfer of Human Tau Between Lamprey Central Neurons in situ
WonHee Kim et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Oxidative Stress: Emerging Mitochondrial and Cellular Themes and Variations in Neuronal Injury
Gavin C. Higgins et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Promoting Successful Cognitive Aging: A Comprehensive Review
Kirk R. Daffner
JOURNAL OF ALZHEIMERS DISEASE (2010)
Immunotherapy Targeting Pathological Tau Prevents Cognitive Decline in a New Tangle Mouse Model
Allal Boutajangout et al.
JOURNAL OF NEUROSCIENCE (2010)
Methylene blue fails to inhibit Tau and polyglutamine protein dependent toxicity in zebrafish
Frauke van Bebber et al.
NEUROBIOLOGY OF DISEASE (2010)
Probing the Biology of Alzheimer's Disease in Mice
Karen H. Ashe et al.
NEURON (2010)
Three Repeat Isoforms of Tau Inhibit Assembly of Four Repeat Tau Filaments
Stephanie J. Adams et al.
PLOS ONE (2010)
A role for FKBP52 in Tau protein function
Beatrice Chambraud et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Sodium selenate mitigates tau pathology, neurodegeneration, and functional deficits in Alzheimer's disease models
Janet van Eersel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Aging Analysis Reveals Slowed Tau Turnover and Enhanced Stress Response in a Mouse Model of Tauopathy
Chad Dickey et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Tau-Focused Immunotherapy for Alzheimer's Disease and Related Tauopathies
Einar M. Sigurdsson
CURRENT ALZHEIMER RESEARCH (2009)
Effectiveness of Donepezil in Reducing Clinical Worsening in Patients with Mild-to-Moderate Alzheimer's Disease
David Wilkinson et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2009)
Phosphorylated Tau Interacts with c-Jun N-terminal Kinase-interacting Protein 1 (JIP1) in Alzheimer Disease
Lars M. Ittner et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Expression of TDP-43 C-terminal Fragments in Vitro Recapitulates Pathological Features of TDP-43 Proteinopathies
Lionel M. Igaz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Propagation of Tau Misfolding from the Outside to the Inside of a Cell
Bess Frost et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Lithium Trial in Alzheimer's Disease: A Randomized, Single-Blind, Placebo-Controlled, Multicenter 10-Week Study
Harald Hampel et al.
JOURNAL OF CLINICAL PSYCHIATRY (2009)
Proteolytic processing of TAR DNA binding protein-43 by caspases produces C-terminal fragments with disease defining properties independent of progranulin
Dorothee Dormann et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease
O. L. Lopez et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2009)
Challenges in the conduct of disease-modifying trials in ad: Practical experience from a phase 2 trial of TAU-aggregation inhibitor therapy
C. Wischik et al.
JOURNAL OF NUTRITION HEALTH & AGING (2009)
The dementia antipsychotic withdrawal trial (DART-AD): long-term follow-up of a randomised placebo-controlled trial
Clive Ballard et al.
LANCET NEUROLOGY (2009)
Transmission and spreading of tauopathy in transgenic mouse brain
Florence Clavaguera et al.
NATURE CELL BIOLOGY (2009)
Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies
Kurt R. Brunden et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Management of agitation and aggression associated with Alzheimer disease
Clive G. Ballard et al.
NATURE REVIEWS NEUROLOGY (2009)
Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease
Mathew Blurton-Jones et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
ALS and FTLD: two faces of TDP-43 proteinopathy
R. M. Liscic et al.
EUROPEAN JOURNAL OF NEUROLOGY (2008)
Improvement in behavioural symptoms in patients with moderate to severe Alzheimer's disease by memantine: a pooled data analysis
S. Gauthier et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2008)
Memantine for agitation/aggression and psychosis in moderately severe to severe Alzheimer's disease: A pooled analysis of 3 studies
Gordon K. Wilcock et al.
JOURNAL OF CLINICAL PSYCHIATRY (2008)
A neuronal microtubule-interacting agent, NAPVSIPQ, reduces tau pathology and enhances cognitive function in a mouse model of Alzheimer's disease
Yasuji Matsuoka et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Long-term effects of Aβ42 immunisation in Alzheimer's disease:: follow-up of a randomised, placebo-controlled phase I trial
Clive Holmes et al.
LANCET (2008)
Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses
Lars Bertram et al.
NATURE REVIEWS NEUROSCIENCE (2008)
Animal models of Alzheimer's disease and frontotemporal dementia
Jurgen Gotz et al.
NATURE REVIEWS NEUROSCIENCE (2008)
Soluble beta-amyloid leads to mitochondrial defects in amyloid precursor protein and tau transgenic mice
Anne Eckert et al.
NEURODEGENERATIVE DISEASES (2008)
Parkinsonism and impaired axonal transport in a mouse model of frontotemporal dementia
Lars M. Ittner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention
K. Iqbal et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
Tau phosphorylation sites work in concert to promote neurotoxicity in vivo
Michelle L. Steinhilb et al.
MOLECULAR BIOLOGY OF THE CELL (2007)
Interaction of tau protein with the dynactin complex
Enrico Magnani et al.
EMBO JOURNAL (2007)
Progranulin mediates caspase-dependent cleavage of TAR DNA binding protein-43
Yong-Jie Zhang et al.
JOURNAL OF NEUROSCIENCE (2007)
Immunotherapy targeting pathological tau conformers in a tangle mouse model reduces brain pathology with associated functional improvements
Ayodeji A. Asuni et al.
JOURNAL OF NEUROSCIENCE (2007)
Roles of heat-shock protein 90 in maintaining and facilitating the neurodegenerative phenotype in tauopathies
Wenjie Luo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Reducing endogenous tau ameliorates amyloid β-induced deficits in an Alzheimer's disease mouse model
Erik D. Roberson et al.
SCIENCE (2007)
Lithium reduces tau phosphorylation but not Aβ or working memory deficits in a transgenic model with both plaques and tangles
Antonella Caccamo et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Effect of pseudophosphorylation and cross-linking by lipid peroxidation and advanced glycation end product precursors on Tau aggregation and filament formation
Bjorn Kuhla et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins
Chad A. Dickey et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Rhodanine-based tau aggregation inhibitors in cell models of tauopathy
Bruno Bulic et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2007)
Tau-mediated neurodegeneration in Alzheimer's disease and related disorders
Carlo Ballatore et al.
NATURE REVIEWS NEUROSCIENCE (2007)
Reduction of soluble Aβ and Tau, but not soluble Aβ alone, ameliorates cognitive decline in transgenic mice with plaques and tangles
Salvatore Oddo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Chronic lithium administration to FTDP-17 tau and GSK-3β overexpressing mice prevents tau hyperphosphorylation and neurofibrillary tangle formation, but pre-formed neurofibrillary tangles do not revert
Tobias Engel et al.
JOURNAL OF NEUROCHEMISTRY (2006)
β-amyloid treatment of two complementary P301 L tau-expressing Alzheimer's disease models reveals similar deregulated cellular processes
Della C. David et al.
PROTEOMICS (2006)
Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis
Manuela Neumann et al.
SCIENCE (2006)
Tauopathy-like abnormalities and neurologic deficits in mice immunized with neuronal tau protein
Hanna Rosenmann et al.
ARCHIVES OF NEUROLOGY (2006)
Do axonal defects in tau and amyloid precursor protein transgenic animals model axonopathy in Alzheimer's disease?
Jurgen Gotz et al.
JOURNAL OF NEUROCHEMISTRY (2006)
An inhibitor of tau hyperphosphorylation prevents severe motor impairments in tau transgenic mice
Sylvie Le Corre et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Active immunization trial in Aβ42-injected P301L tau transgenic mice
L Kulic et al.
NEUROBIOLOGY OF DISEASE (2006)
Inducible expression of tau repeat domain in cell models of tauopathy - Aggregation is toxic to cells but can be reversed by inhibitor drugs
I Khlistunova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Tau phosphorylation, aggregation, and cell toxicity
J. Avila et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2006)
Neuroleptic drugs in dementia: benefits and harm
Clive Ballard et al.
NATURE REVIEWS NEUROSCIENCE (2006)
Different tau epitopes define Aβ42-mediated tau insolubility
L Pennanen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Disease-related modifications in tau affect the interaction between Fyn and tau
K Bhaskar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Fyn kinase induces synaptic and cognitive impairments in a Transgenic mouse model of Alzheimer's disease
J Chin et al.
JOURNAL OF NEUROSCIENCE (2005)
Axonal degeneration induced by targeted expression of mutant human tau in oligodendrocytes of transgenic mice that model glial tauopathies
M Higuchi et al.
JOURNAL OF NEUROSCIENCE (2005)
Effects of α-synuclein immunization in a mouse model of Parkinson's disease
E Masliah et al.
NEURON (2005)
Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms
C Andorfer et al.
JOURNAL OF NEUROSCIENCE (2005)
Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo
W Noble et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Anthraquinones inhibit tau aggregation and dissolve Alzheimer's paired helical filaments in vitro and in cells
M Pickhardt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Extensive involvement of autophagy in Alzheimer disease: An immuno-electron microscopy study
RA Nixon et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2005)
Microtubule-binding drugs offset tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a tauopathy model
B Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
CHIP and Hsp70 regulate tau ubiquitination, degradation and aggregation
L Petrucelli et al.
HUMAN MOLECULAR GENETICS (2004)
Accelerated extinction of conditioned taste aversion in P301L tau transgenic mice
L Pennanen et al.
NEUROBIOLOGY OF DISEASE (2004)
Phosphorylation of tau by fyn: Implications for Alzheimer's disease
G Lee et al.
JOURNAL OF NEUROSCIENCE (2004)
Aβ immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome
S Oddo et al.
NEURON (2004)
Posttranslational modifications of tau -: Role in human tauopathies and modeling in transgenic animals
F Chen et al.
CURRENT DRUG TARGETS (2004)
Passive amyloid immunotherapy clears amyloid and transiently activates microglia in a transgenic mouse model of amyloid deposition
DM Wilcock et al.
JOURNAL OF NEUROSCIENCE (2004)
Reference genes identified in SH-SY5Y cells using custom-made gene arrays with validation by quantitative polymerase chain reaction
FJ Hoerndli et al.
ANALYTICAL BIOCHEMISTRY (2004)
Alzheimer's disease Aβ vaccine reduces central nervous system Aβ levels in a non-human primate, the Caribbean Vervet
CA Lemere et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Role for glyoxalase I in Alzheimer's disease
F Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Fyn kinase modulates synaptotoxicity, but not aberrant sprouting, in human amyloid precursor protein transgenic mice
J Chin et al.
JOURNAL OF NEUROSCIENCE (2004)
β-amyloid induces paired helical filament-like tau filaments in tissue culture
A Ferrari et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Activation of the ERK and JNK signaling pathways caused by neuron-specific inhibition of PP2A in transgenic mice
S Kins et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization
JM Orgogozo et al.
NEUROLOGY (2003)
Antibodies against β-amyloid slow cognitive decline in Alzheimer's disease
C Hock et al.
NEURON (2003)
14-3-3 connects glycogen synthase kinase-3β to tau within a brain microtubule-associated tau phosphorylation complex
A Agarwal-Mawal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Proteasome inhibition by paired helical filament-tau in brains of patients with Alzheimer's disease
S Keck et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Chronic lithium treatment decreases mutant tau protein aggregation in a transgenic mouse model
Mar Perez et al.
JOURNAL OF ALZHEIMERS DISEASE (2003)
Proteasomal degradation of tau protein
DC David et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Transgenic mouse model of tauopathies with glial pathology and nervous system degeneration
M Higuchi et al.
NEURON (2002)
Glycogen synthase kinase-3,β is complexed with tau protein in brain microtubules
W Sun et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Formation of neurofibrillary tangles in P301L tau transgenic mice induced by Aβ42 fibrils
J Götz et al.
SCIENCE (2001)
Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP
J Lewis et al.
SCIENCE (2001)
Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease
RB DeMattos et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Age-dependent induction of congophilic neurofibrillary tau inclusions in tau transgenic mice
T Ishihara et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Tau filament formation in transgenic mice expressing P301L tau
J Götz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Neurodegenerative tauopathies
VMY Lee et al.
ANNUAL REVIEW OF NEUROSCIENCE (2001)
Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
D Morgan et al.
NATURE (2000)
Immature human NT2 cells grafted into mouse brain differentiate into neuronal and glial cell types
A Ferrari et al.
FEBS LETTERS (2000)
Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease
F Bard et al.
NATURE MEDICINE (2000)
Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein
A Probst et al.
ACTA NEUROPATHOLOGICA (2000)
分享论文
